Back to Awarded Treatment Trials
Awarded Trial: 02-STN-008-1
Grant ID
02-STN-008-1
Illness
Schizophrenia
Primary Drug/Intervention
Amoxapine
Primary Dosage
N/A
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Kapur
Sample Size
12
Duration of Study Period for Each Subject
N/A
Outcome Measurements
N/A
Results
In a preliminary trial with 15 patients, the off-patent antidepressant amoxapine showed signs of efficacy as an atypical antipsychotic. A double-blind trial is now underway to confirm this.
Publication
Sampson S, Hosalli P, Furtado VA, Davis JM. Risperidone (depot) for schizophrenia. Cochrane Database Syst Rev. 2016 Apr 14;4:CD004161.
Link
http://www.ncbi.nlm.nih.gov/pubmed/27078222
PI Name
Shitij Kapur
Degree
MD
Center
Centre for Addiction and Mental Health
Institution
Clarke Institute
Address
250 College Street
City or Town
Toronto
State or Province
Ontario
Zip or Postal Code
M5T 1RB
Country
Canada
Email Address
kapur@clarke-inst.on.ca